Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Over the past fifty years, many successful organ transplants have occurred. The first successful adult human kidney transplant was performed in 1954 and transplants today now involve every major organ. Transplantation of various organs, tissues, and cells (such as kidneys, hearts, lungs, livers, bone marrow, and others) are now possible in children. Survival is steadily increasing and successful transplants now lead to an improved quality of life.
With the number of people needing transplants increasing each year, the various organizations, as well as healthcare providers, are increasing the public's awareness of the need for organ donation.
Medical technology continues to improve and transplantation has become a life-saving procedure for many people with congenital or chronic conditions or diseases. Research studies continue to focus on preventing graft rejection and the development of new anti-rejection drugs and therapies that are less toxic and more effective.
Scientists also continue to learn about the body's immune system, which contributes to a further understanding of transplantation and other immunologic diseases and conditions.
Solid organ transplantation programs at Stanford Health Care offer patients a variety of specialty services to address serious medical problems. Services include careful pre-transplant monitoring and post-surgical care. Our medical teams offer transplantation services for the following:
Depending on the subspecialty, Stanford also offers:
Living donor transplantation
Partial organ transplants
Our transplant teams provide superior specialized expertise in all related services.
Stanford strongly emphasizes continuous quality improvement (CQI) in its transplant programs and maintains comprehensive outpatient management of transplant recipients that includes infection prophylaxis, management of immunosuppression, and long-term patient monitoring and care.
After receiving a lung transplant at Stanford Health Care because of cystic fibrosis, Erinn Hoyt participated in the 2017 World Transplant Games.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referring Physicians.
Track your patients' progress and communicate with Stanford providers securely online.